Article Information
History
- March 13, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Jeanette Stålcrantz1,2,*,
- Anja Bråthen Kristoffersen3,
- Håkon Bøås1,
- Lamprini Veneti4,
- Elina Seppälä1,
- Nina Aasand5,
- Olav Hungnes6,
- Reidar Kvåle7,8,
- Karoline Bragstad6,
- Eirik Alnes Buanes7,9 and
- Robert Whittaker1
- 1Department of Infection Control and Vaccines, Norwegian Institute of Public Health, Oslo, Norway
- 2European Program for Intervention Epidemiology Training, European Centre for Disease Prevention and Control, Stockholm, Sweden
- 3Department of Method Development and Analytics, Norwegian Institute of Public Health, Oslo, Norway
- 4Department of Infection Control and Preparedness, Norwegian Institute of Public Health, Oslo, Norway
- 5Department of Infectious Disease Registries, Norwegian Institute of Public Health, Oslo, Norway
- 6Department of Virology, Norwegian Institute of Public Health, Oslo, Norway
- 7Department of Anaesthesia and Intensive Care, Haukeland University Hospital, Bergen, Norway
- 8Department of Clinical Medicine, University of Bergen, Bergen, Norway
- 9Norwegian Intensive Care and Pandemic Registry, Haukeland University Hospital, Bergen, Norway
- ↵*Corresponding author. Address: Norwegian Institute of Public Health, Lovisenberggata 8, 0456 Oslo, Norway. Email address: jeanette.stalcrantz{at}fhi.no
Posted March 13, 2022.
Milder disease trajectory among COVID-19 patients hospitalised with the SARS-CoV-2 Omicron variant compared with the Delta variant in Norway
